US 8,425,934 · Application 11/841,030 · Granted Apr 23, 2013
US 8,425,934
Pharmaceutical compositions
Estimated expiration
April 17, 2030
3y 216d remaining
Earliest effective filing
Aug 20, 2007
+ 20 years
Aug 20, 2027
PTA +971d
Apr 17, 2030
No TD
—
Final
Apr 17, 2030
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.
Calculation details
Base term
- Filing date
- August 20, 2007
- Earliest effective filing
- August 20, 2007
- Issue date
- April 23, 2013
- PTA
- +971 days
- Base expiry (before PTA)
- August 20, 2027
August 20, 2007 + 20 years = August 20, 2027 + 971 PTA days = April 17, 2030
- PRO60/823,083 — Provisional — not used for base term
Terminal disclaimers
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 11/841,030 · US 8,425,934
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 8,425,934: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US8425934Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.